Health care workers (HCW) are a high-risk population to acquire SARS-CoV-2 infection from patients or other fellow HCW. This study aims at estimating the seroprevalence against SARS-CoV-2 in a random sample of HCW from a large hospital in Spain. Of the 578 participants recruited from 28 March to 9 April 2020, 54 (9.3%, 95% CI: 7.1-12.0) were seropositive for IgM and/or IgG and/or IgA against SARS-CoV-2. The cumulative prevalence of SARS-CoV-2 infection (presence of antibodies or past or current positive rRT-PCR) was 11.2% (65/578, 95% CI: 8.8-14.1). Among those with evidence of past or current infection, 40.0% (26/65) had not been previously diagnosed with COVID-19. Here we report a relatively low seroprevalence of antibodies among HCW at the peak of the COVID-19 epidemic in Spain. A large proportion of HCW with past or present infection had not been previously diagnosed with COVID-19, which calls for active periodic rRT-PCR testing in hospital settings.
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital.
西班牙一家大型参考医院医护人员中SARS-CoV-2抗体的血清阳性率
阅读:9
作者:Garcia-Basteiro Alberto L, Moncunill Gemma, Tortajada Marta, Vidal Marta, Guinovart Caterina, Jiménez Alfons, Santano Rebeca, Sanz Sergi, Méndez Susana, Llupià Anna, Aguilar Ruth, Alonso Selena, Barrios Diana, Carolis Carlo, Cisteró Pau, Chóliz Eugenia, Cruz Angeline, Fochs Silvia, Jairoce Chenjerai, Hecht Jochen, Lamoglia Montserrat, MartÃnez Mikel J, Mitchell Robert A, Ortega Natalia, Pey Nuria, Puyol Laura, Ribes Marta, Rosell Neus, Sotomayor Patricia, Torres Sara, Williams Sarah, Barroso Sonia, Vilella Anna, Muñoz José, Trilla Antoni, Varela Pilar, Mayor Alfredo, Dobaño Carlota
| 期刊: | Nature Communications | 影响因子: | 15.700 |
| 时间: | 2020 | 起止号: | 2020 Jul 8; 11(1):3500 |
| doi: | 10.1038/s41467-020-17318-x | 研究方向: | 炎症/感染 |
| 疾病类型: | 新冠 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
